Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Paul Ausick | Nov 6, 2018 at 9:10 AM EST

CVS Earnings, Merger With Aetna Look Good to Investors

CVS reported third-quarter results Tuesday morning that beat estimates on both the top and bottom lines. The company also said…

Chris Lange | Nov 6, 2018 at 8:35 AM EST

What Drove Mylan Earnings in Q3

Mylan reported better-than-expected quarterly results late Monday, and shares rose sharply in Friday's premarket.

Chris Lange | Nov 5, 2018 at 12:35 PM EST

Vapotherm Gears Up for IPO

Medical technology company Vapotherm intends to price 4 million shares for and initial public offering valued up to more than…

Chris Lange | Nov 5, 2018 at 11:25 AM EST

What to Watch For When Eli Lilly Reports Tuesday Morning

Eli Lilly is scheduled to release its most recent quarterly results before the markets open on Tuesday.

Chris Lange | Nov 5, 2018 at 10:35 AM EST

Why Clearside Biomedical Shares Were Halved

Clearside Biomedical shares were halved early on Monday after the firm reported results from its late-stage Sapphire trial.

Chris Lange | Nov 2, 2018 at 10:23 AM EDT

AbbVie Little Changed Despite Big Bottom-Line Beat

AbbVie released its third quarter financial results before the markets opened on Friday. The pharma giant said that it had…

Chris Lange | Nov 2, 2018 at 9:19 AM EDT

Why the FDA Is Dragging Alkermes Down

Alkermes shares dropped early on Friday after the company anncounced the results from its most recent meeting with the U.S.…

Chris Lange | Nov 1, 2018 at 9:50 AM EDT

The Drag on Teva’s Q3 Results

Teva Pharmaceutical released its most recent earnings report before the markets opened on Thursday.

Chris Lange | Oct 31, 2018 at 1:35 PM EDT

KemPharm Lands New License Deal for Apadaz

KemPharm shares made a handy gain on Wednesday after the firm announced a new license agreement with KVK Tech for…

Chris Lange | Oct 31, 2018 at 12:15 PM EDT

Acadia Pharma Slides Despite Positive Major Depressive Disorder Results

Acadia Pharmaceuticals shares dipped on Wednesday despite announcing positive top-line results from its Clarity mid-stage study in major depressive disorder…

Chris Lange | Oct 31, 2018 at 10:55 AM EDT

Merck Wins Yet Again With New Keytruda Approval

Merck shares were up slightly on Wednesday after the pharma giant gave another key update for its KEYTRUDA line. The…

Chris Lange | Oct 30, 2018 at 8:40 AM EDT

Why Pfizer Is Tripping Over Itself With Earnings

Pfizer reported mixed quarterly results before the markets opened on Tuesday and shares retreated in the premarket.

Chris Lange | Oct 29, 2018 at 12:35 PM EDT

Melinta Therapeutics Loses Again Despite Positive Phase 3 Results

Melinta Therapeutics shares dropped on Monday despite the company announcing positive top-line results from its Phase 3 trial of Baxdela…

Chris Lange | Oct 29, 2018 at 11:25 AM EDT

What to Watch For When Pfizer Reports Tuesday Morning

Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 29, 2018 at 9:45 AM EDT

Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology

Dicerna Pharmaceuticals and Eli Lilly are partnering up in a global licensing and research collaboration focused on the discovery, development…

1 … 114 115 116 117 118 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

CVS Earnings, Merger With Aetna Look Good to Investors

What Drove Mylan Earnings in Q3

Vapotherm Gears Up for IPO

What to Watch For When Eli Lilly Reports Tuesday Morning

Why Clearside Biomedical Shares Were Halved

AbbVie Little Changed Despite Big Bottom-Line Beat

Why the FDA Is Dragging Alkermes Down

The Drag on Teva’s Q3 Results

KemPharm Lands New License Deal for Apadaz

Acadia Pharma Slides Despite Positive Major Depressive Disorder Results

Merck Wins Yet Again With New Keytruda Approval

Why Pfizer Is Tripping Over Itself With Earnings

Melinta Therapeutics Loses Again Despite Positive Phase 3 Results

What to Watch For When Pfizer Reports Tuesday Morning

Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

50% of Nvidia Employees Are Now Worth Over $25 Million: How Nvidia Created Thousands of Millionaires

Want $2,200 in Passive Income? Invest $50,000 Into These 3 Dividend Stocks

Does Lumentum’s 1,444% Surge Come to an End Tomorrow?

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Ben Carlson Calls Out the Goldman Survey That Says 40% of $500K Earners Live Paycheck-to-Paycheck. The Definition Is the Problem.

50% of Nvidia Employees Are Now Worth Over $25 Million: How Nvidia Created Thousands of Millionaires

Want $2,200 in Passive Income? Invest $50,000 Into These 3 Dividend Stocks

Health and Healthcare Articles

All Health and Healthcare Articles

CVS Earnings, Merger With Aetna Look Good to Investors

What Drove Mylan Earnings in Q3

Vapotherm Gears Up for IPO

What to Watch For When Eli Lilly Reports Tuesday Morning

Why Clearside Biomedical Shares Were Halved

AbbVie Little Changed Despite Big Bottom-Line Beat

Why the FDA Is Dragging Alkermes Down

The Drag on Teva’s Q3 Results

KemPharm Lands New License Deal for Apadaz

Acadia Pharma Slides Despite Positive Major Depressive Disorder Results

Merck Wins Yet Again With New Keytruda Approval

Why Pfizer Is Tripping Over Itself With Earnings

Melinta Therapeutics Loses Again Despite Positive Phase 3 Results

What to Watch For When Pfizer Reports Tuesday Morning

Dicerna Pharma Teams Up With Eli Lilly for RNAi Technology

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

50% of Nvidia Employees Are Now Worth Over $25 Million: How Nvidia Created Thousands of Millionaires

Want $2,200 in Passive Income? Invest $50,000 Into These 3 Dividend Stocks

Does Lumentum’s 1,444% Surge Come to an End Tomorrow?

Featured Reads

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Ben Carlson Calls Out the Goldman Survey That Says 40% of $500K Earners Live Paycheck-to-Paycheck. The Definition Is the Problem.